For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, Harvard Bioscience Inc (NASDAQ: HBIO) closed at $0.51 up 0.08% from its previous closing price of $0.51. In other words, the price has increased by $0.08 from its previous closing price. On the day, 1.2 million shares were traded.
Ratios:
For a deeper understanding of Harvard Bioscience Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 59.26. For the most recent quarter (mrq), Quick Ratio is recorded 0.40 and its Current Ratio is at 0.81. In the meantime, Its Debt-to-Equity ratio is 3.01 whereas as Long-Term Debt/Eq ratio is at 0.49.
On March 10, 2023, The Benchmark Company Upgraded its rating to Buy which previously was Speculative Buy and also upped its target price recommendation from $3 to $4.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25 while its Price-to-Book (P/B) ratio in mrq is 1.52.
Stock Price History:
Over the past 52 weeks, HBIO has reached a high of $3.60, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is 28.67%, while the 200-Day Moving Average is calculated to be -67.07%.
Shares Statistics:
A total of 44.21M shares are outstanding, with a floating share count of 37.41M. Insiders hold about 15.39% of the company’s shares, while institutions hold 58.64% stake in the company.
